Multiple sclerosis: glial cell diversity in time and space: special issue article

Multiple sclerosis (MS) is the most prevalent human inflammatory disease of the central nervous system with demyelination and glial scar formation as pathological hallmarks. Glial cells are key drivers of lesion progression in MS with roles in both tissue damage and repair depending on the surroundi...

Full description

Saved in:
Bibliographic Details
Main Authors: Kooistra, Susanne M. (Author) , Schirmer, Lucas (Author)
Format: Article (Journal)
Language:English
Published: March 2025
In: Glia
Year: 2025, Volume: 73, Issue: 3, Pages: 574-590
ISSN:1098-1136
DOI:10.1002/glia.24655
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/glia.24655
Verlag, kostenfrei, Volltext: http://onlinelibrary.wiley.com/doi/abs/10.1002/glia.24655
Get full text
Author Notes:Susanne M. Kooistra, Lucas Schirmer
Description
Summary:Multiple sclerosis (MS) is the most prevalent human inflammatory disease of the central nervous system with demyelination and glial scar formation as pathological hallmarks. Glial cells are key drivers of lesion progression in MS with roles in both tissue damage and repair depending on the surrounding microenvironment and the functional state of the individual glial subtype. In this review, we describe recent developments in the context of glial cell diversity in MS summarizing key findings with respect to pathological and maladaptive functions related to disease-associated glial subtypes. A particular focus is on the spatial and temporal dynamics of glial cells including subtypes of microglia, oligodendrocytes, and astrocytes. We contextualize recent high-dimensional findings suggesting that glial cells dynamically change with respect to epigenomic, transcriptomic, and metabolic features across the inflamed rim and during the progression of MS lesions. In summary, detailed knowledge of spatially restricted glial subtype functions is critical for a better understanding of MS pathology and its pathogenesis as well as the development of novel MS therapies targeting specific glial cell types.
Item Description:Erstmals veröffentlicht: 24. Dezember 2024
Gesehen am 15.05.2025
Physical Description:Online Resource
ISSN:1098-1136
DOI:10.1002/glia.24655